Adherence to long‐term anticoagulation treatment, what is known and what the future might hold
Summary Adherence to medication, commonly reported as being 50% in chronic diseases, is of great concern in healthcare. Medication non‐adherence is particularly apparent in chronic diseases, where treatment is often preventative and may provide little or no symptomatic relief or feedback for the pat...
Gespeichert in:
Veröffentlicht in: | British journal of haematology 2016-07, Vol.174 (1), p.30-42 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 42 |
---|---|
container_issue | 1 |
container_start_page | 30 |
container_title | British journal of haematology |
container_volume | 174 |
creator | Abdou, John K. Auyeung, Vivian Patel, Jignesh P. Arya, Roopen |
description | Summary
Adherence to medication, commonly reported as being 50% in chronic diseases, is of great concern in healthcare. Medication non‐adherence is particularly apparent in chronic diseases, where treatment is often preventative and may provide little or no symptomatic relief or feedback for the patient. A lot of research has been undertaken to describe the extent of non‐adherence to long‐term anticoagulation therapy, particularly with vitamin K antagonists and more recently with direct oral anticoagulants. However, the literature is scarce with respect to describing adherence to anticoagulation in terms of the behavioural aspects that influence medicine use. Utilizing the COM‐B (capability, opportunity, motivation and behaviour) psychological model of non‐adherence, we present the available evidence, not only in terms of describing the extent of the non‐adherence problem, but also describing why patients do not adhere, offering theory‐driven and evidence‐based solutions to improve long‐term adherence to chronic anticoagulation therapy. Lessons learned are not only applicable within the field of anticoagulation but throughout haematology. |
doi_str_mv | 10.1111/bjh.14134 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808639175</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1799205231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4634-f9f3e584fc78eed4acc45cfac3979a518b9ca65d4c13f3313815a6e865173e03</originalsourceid><addsrcrecordid>eNqFkE1OwzAQRi0EoqWw4ALIS5BIa9d2fpalAgqqxKb74DqTJiWJi-2o6o4jcEZOgiGFHWI2oxk9faN5CJ1TMqS-Rst1MaScMn6A-pSFIhj76RD1CSFRQAmPe-jE2jUhlBFBj1FvHNGIRTzso-dJVoCBRgF2Gle6WX28vTswNZaNK5WWq7aSrtQNdgakq6Fx13hbSIdLi18avW08mHUbVwDOW9cawHW5KhwudJWdoqNcVhbO9n2AFne3i-ksmD_dP0wn80DxkPEgT3IGIua5imKAjEuluFC5VCyJEilovEyUDEXGFWU5Y5TFVMgQ4lD4T4CwAbrsYjdGv7ZgXVqXVkFVyQZ0a1MakzhkCY3E_2iUJGMixv7IAF11qDLaWgN5ujFlLc0upST9Up969em3es9e7GPbZQ3ZL_nj2gOjDtiWFez-TkpvHmdd5CfWiY5H</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1799205231</pqid></control><display><type>article</type><title>Adherence to long‐term anticoagulation treatment, what is known and what the future might hold</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Abdou, John K. ; Auyeung, Vivian ; Patel, Jignesh P. ; Arya, Roopen</creator><creatorcontrib>Abdou, John K. ; Auyeung, Vivian ; Patel, Jignesh P. ; Arya, Roopen</creatorcontrib><description>Summary
Adherence to medication, commonly reported as being 50% in chronic diseases, is of great concern in healthcare. Medication non‐adherence is particularly apparent in chronic diseases, where treatment is often preventative and may provide little or no symptomatic relief or feedback for the patient. A lot of research has been undertaken to describe the extent of non‐adherence to long‐term anticoagulation therapy, particularly with vitamin K antagonists and more recently with direct oral anticoagulants. However, the literature is scarce with respect to describing adherence to anticoagulation in terms of the behavioural aspects that influence medicine use. Utilizing the COM‐B (capability, opportunity, motivation and behaviour) psychological model of non‐adherence, we present the available evidence, not only in terms of describing the extent of the non‐adherence problem, but also describing why patients do not adhere, offering theory‐driven and evidence‐based solutions to improve long‐term adherence to chronic anticoagulation therapy. Lessons learned are not only applicable within the field of anticoagulation but throughout haematology.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.14134</identifier><identifier>PMID: 27173746</identifier><language>eng</language><publisher>England</publisher><subject>Anticoagulants - therapeutic use ; atrial fibrillation ; direct oral anticoagulants ; Humans ; Long-Term Care ; medication adherence ; Medication Adherence - psychology ; Models, Psychological ; venous thromboembolism ; vitamin K antagonists</subject><ispartof>British journal of haematology, 2016-07, Vol.174 (1), p.30-42</ispartof><rights>2016 John Wiley & Sons Ltd</rights><rights>2016 John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4634-f9f3e584fc78eed4acc45cfac3979a518b9ca65d4c13f3313815a6e865173e03</citedby><cites>FETCH-LOGICAL-c4634-f9f3e584fc78eed4acc45cfac3979a518b9ca65d4c13f3313815a6e865173e03</cites><orcidid>0000-0002-9294-3174</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjh.14134$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjh.14134$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27173746$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abdou, John K.</creatorcontrib><creatorcontrib>Auyeung, Vivian</creatorcontrib><creatorcontrib>Patel, Jignesh P.</creatorcontrib><creatorcontrib>Arya, Roopen</creatorcontrib><title>Adherence to long‐term anticoagulation treatment, what is known and what the future might hold</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary
Adherence to medication, commonly reported as being 50% in chronic diseases, is of great concern in healthcare. Medication non‐adherence is particularly apparent in chronic diseases, where treatment is often preventative and may provide little or no symptomatic relief or feedback for the patient. A lot of research has been undertaken to describe the extent of non‐adherence to long‐term anticoagulation therapy, particularly with vitamin K antagonists and more recently with direct oral anticoagulants. However, the literature is scarce with respect to describing adherence to anticoagulation in terms of the behavioural aspects that influence medicine use. Utilizing the COM‐B (capability, opportunity, motivation and behaviour) psychological model of non‐adherence, we present the available evidence, not only in terms of describing the extent of the non‐adherence problem, but also describing why patients do not adhere, offering theory‐driven and evidence‐based solutions to improve long‐term adherence to chronic anticoagulation therapy. Lessons learned are not only applicable within the field of anticoagulation but throughout haematology.</description><subject>Anticoagulants - therapeutic use</subject><subject>atrial fibrillation</subject><subject>direct oral anticoagulants</subject><subject>Humans</subject><subject>Long-Term Care</subject><subject>medication adherence</subject><subject>Medication Adherence - psychology</subject><subject>Models, Psychological</subject><subject>venous thromboembolism</subject><subject>vitamin K antagonists</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1OwzAQRi0EoqWw4ALIS5BIa9d2fpalAgqqxKb74DqTJiWJi-2o6o4jcEZOgiGFHWI2oxk9faN5CJ1TMqS-Rst1MaScMn6A-pSFIhj76RD1CSFRQAmPe-jE2jUhlBFBj1FvHNGIRTzso-dJVoCBRgF2Gle6WX28vTswNZaNK5WWq7aSrtQNdgakq6Fx13hbSIdLi18avW08mHUbVwDOW9cawHW5KhwudJWdoqNcVhbO9n2AFne3i-ksmD_dP0wn80DxkPEgT3IGIua5imKAjEuluFC5VCyJEilovEyUDEXGFWU5Y5TFVMgQ4lD4T4CwAbrsYjdGv7ZgXVqXVkFVyQZ0a1MakzhkCY3E_2iUJGMixv7IAF11qDLaWgN5ujFlLc0upST9Up969em3es9e7GPbZQ3ZL_nj2gOjDtiWFez-TkpvHmdd5CfWiY5H</recordid><startdate>201607</startdate><enddate>201607</enddate><creator>Abdou, John K.</creator><creator>Auyeung, Vivian</creator><creator>Patel, Jignesh P.</creator><creator>Arya, Roopen</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0002-9294-3174</orcidid></search><sort><creationdate>201607</creationdate><title>Adherence to long‐term anticoagulation treatment, what is known and what the future might hold</title><author>Abdou, John K. ; Auyeung, Vivian ; Patel, Jignesh P. ; Arya, Roopen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4634-f9f3e584fc78eed4acc45cfac3979a518b9ca65d4c13f3313815a6e865173e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anticoagulants - therapeutic use</topic><topic>atrial fibrillation</topic><topic>direct oral anticoagulants</topic><topic>Humans</topic><topic>Long-Term Care</topic><topic>medication adherence</topic><topic>Medication Adherence - psychology</topic><topic>Models, Psychological</topic><topic>venous thromboembolism</topic><topic>vitamin K antagonists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdou, John K.</creatorcontrib><creatorcontrib>Auyeung, Vivian</creatorcontrib><creatorcontrib>Patel, Jignesh P.</creatorcontrib><creatorcontrib>Arya, Roopen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdou, John K.</au><au>Auyeung, Vivian</au><au>Patel, Jignesh P.</au><au>Arya, Roopen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adherence to long‐term anticoagulation treatment, what is known and what the future might hold</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2016-07</date><risdate>2016</risdate><volume>174</volume><issue>1</issue><spage>30</spage><epage>42</epage><pages>30-42</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><abstract>Summary
Adherence to medication, commonly reported as being 50% in chronic diseases, is of great concern in healthcare. Medication non‐adherence is particularly apparent in chronic diseases, where treatment is often preventative and may provide little or no symptomatic relief or feedback for the patient. A lot of research has been undertaken to describe the extent of non‐adherence to long‐term anticoagulation therapy, particularly with vitamin K antagonists and more recently with direct oral anticoagulants. However, the literature is scarce with respect to describing adherence to anticoagulation in terms of the behavioural aspects that influence medicine use. Utilizing the COM‐B (capability, opportunity, motivation and behaviour) psychological model of non‐adherence, we present the available evidence, not only in terms of describing the extent of the non‐adherence problem, but also describing why patients do not adhere, offering theory‐driven and evidence‐based solutions to improve long‐term adherence to chronic anticoagulation therapy. Lessons learned are not only applicable within the field of anticoagulation but throughout haematology.</abstract><cop>England</cop><pmid>27173746</pmid><doi>10.1111/bjh.14134</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-9294-3174</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1048 |
ispartof | British journal of haematology, 2016-07, Vol.174 (1), p.30-42 |
issn | 0007-1048 1365-2141 |
language | eng |
recordid | cdi_proquest_miscellaneous_1808639175 |
source | Wiley Free Content; MEDLINE; Wiley Online Library All Journals |
subjects | Anticoagulants - therapeutic use atrial fibrillation direct oral anticoagulants Humans Long-Term Care medication adherence Medication Adherence - psychology Models, Psychological venous thromboembolism vitamin K antagonists |
title | Adherence to long‐term anticoagulation treatment, what is known and what the future might hold |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T17%3A14%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adherence%20to%20long%E2%80%90term%20anticoagulation%20treatment,%20what%20is%20known%20and%20what%20the%20future%20might%20hold&rft.jtitle=British%20journal%20of%20haematology&rft.au=Abdou,%20John%20K.&rft.date=2016-07&rft.volume=174&rft.issue=1&rft.spage=30&rft.epage=42&rft.pages=30-42&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.14134&rft_dat=%3Cproquest_cross%3E1799205231%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1799205231&rft_id=info:pmid/27173746&rfr_iscdi=true |